Major Ingredients

Ceftazidime USP 250mg Injection.

Major Functionality

It is indicated for the treatment of single infections and for mixed infections caused by susceptible organisms. S evere infections in general : for example septicaemia, bacteraemia, peritonitis, meningitis, infections in immunosuppressed patients and in patients in intensive care units with specific problems. R espiratory tract infections : for example, pneumonia, bronchopneumonia, infected pleuris y, empyema, lung abs cess, infected bronchiectasis, bronchitis and lung infections in patients with cystic fibrosis. E ar, nose and throat infections : otitis media, otitis externa, mastoiditis, sinusitis and other severe ear and throat infections. Urinary tract infections: acute and chronic pyelonephritis, pyelitis, prostatitis, cystitis, urethritis, renal abscess. S kin and soft tissue infections: abscess, cellulitis, infected burn and wounds, skin ulcers etc. Gastrointestinal biliary and abdominal infections : cholangitis, cholecystitis, intraabdominal abscess, peritonitis etc. Bone and joint infections : Osteomyelitis, septic arthritis etc.

Manufacture Information

Drug International Limited was incorporated under the Registrar of Joint Stock Companies in 1974 as a Private Limited Company. The company commenced formulation and production in 1983 and emerged as a pioneer in Bangladesh for adding a state of the art oral solid dosage plant. Since inception, Drug International Limited's primary objective has been to meet guidelines provided by major global regulatory bodies such as the World Health Organization Good Manufacturing Practices (WHO cGMP) guidelines.